🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Abiomed clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our USA and UK registers with Abiomed as lead sponsor. Synced 26 Sep 2026
9Current trials
2Recruiting now
0Drugs in these trials
2Trial registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Abiomed is the lead sponsor of 9 current clinical trials in our USA and UK registers. 2 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Heart Failure.

ClinicalTrials.gov trials by status

  • Recruiting222%
  • Not yet open111%
  • Active, closed556%
  • By invitation111%

Trials by phase

  • Not applicable778%
  • Observational222%
01

Clinical trials sponsored by Abiomed

9 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
NCT06964685 · ClinicalTrials.gov ↗ · AMI Cardiogenic Shock
Observational Recruiting 2025-07 USA
Impella RP Flex with Smart Assist
NCT06637644 · ClinicalTrials.gov ↗ · Right Ventricular (RV) Dysfunction
Observational Recruiting 2024-05 USA
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
NCT06965504 · ClinicalTrials.gov ↗ · Heart Failure, Cardiogenic Shock, Reduced Ejection Fraction Heart Failure
Not applicable Not yet open 2026-09 USA
Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol
NCT05334784 · ClinicalTrials.gov ↗ · High-Risk Percutaneous Coronary Intervention
Not applicable By invitation 2022-12 USA
Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial
NCT03947619 · ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
Not applicable Active, closed 2019-12 UK, USA
The Smart Pump Study
NCT04465201 · Cardiac Output
Not applicable Active, closed 2020-11 USA
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function
NCT04763200 · ClinicalTrials.gov ↗ · Left Ventricular Dysfunction, Coronary Artery Disease
Not applicable Active, closed 2021-04 UK, USA
Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study
NCT05291884 · ClinicalTrials.gov ↗ · Heart Failure, Acute Decompensated Heart Failure
Not applicable Active, closed 2022-04 USA
Impella ECP Early Feasibility Study
NCT04477603 · ClinicalTrials.gov ↗ · High-risk Percutaneous Coronary Intervention
Not applicable Active, closed 2020-10 USA

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Abiomed trials

12 conditions
Heart Failure2ST Elevation (STEMI) Myocardial Infarction of Anterior Wall1Left Ventricular Dysfunction1Coronary Artery Disease1Cardiac Output1AMI Cardiogenic Shock1Acute Decompensated Heart Failure1Right Ventricular (RV) Dysfunction1High-Risk Percutaneous Coronary Intervention1Cardiogenic Shock1Reduced Ejection Fraction Heart Failure1High-risk Percutaneous Coronary Intervention1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in USA92
Clinical trials in UK20

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Heart Failure

SponsorTrials
Ruijin Hospital5
Jiangsu Taizhou People's Hospital5
Impulse Dynamics4
Foundry Innovation & Research 1, Limited (FIRE1)3
Medtronic3
Heartfelt Technologies3
Medtronic Cardiac Rhythm and Heart Failure3
Corvia Medical3
HELP Therapeutics3
Endotronix2

Sponsors with the most current trials registered for this condition.

05

Questions about Abiomed trials

How many clinical trials does Abiomed sponsor?

Abiomed is the lead sponsor of 9 current trials on ClinicalTrials.gov in our USA and UK registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Abiomed trials recruiting?

Yes. 2 of its 9 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.